Evidence map›Paper›PMID 20165923›Full record

ArticleMolecular biology reports2011

Prevalence of known mutations in the MEFV gene in a population screening with high rate of carriers.

Oztürk Ozdemir, Ilhan Sezgin, Hande Kucuk Kurtulgan, Ferhan Candan, Binnur Koksal, Haldun Sumer, Dilara Icagasioglu, Atilla Uslu, Fazilet Yildiz, Sulhattin Arslan and 4 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. TheBalkan journal of medical genetics : BJMG · 2016
    Article
  5. Article
  6. Article
  7. The Relationship between NALP3 and Autoinflammatory Syndromes.International journal of molecular sciences · 2016
    Review
  8. Article
  9. Article
  10. MEFV mutations in Northwest of Iran: a cross sectional study.Iranian journal of basic medical sciences · 2015
    Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Oztürk OzdemirDepartment of Medical Genetics, Faculty of Medicine, Cumhuriyet University, 58140 Sivas, Turkey. ozdemiro@cumhuriyet.edu.tr
Ilhan Sezgin
Hande Kucuk Kurtulgan
Ferhan Candan
Binnur Koksal
Haldun Sumer
Dilara Icagasioglu
Atilla Uslu
Fazilet Yildiz
Sulhattin Arslan
Selma Cetinkaya
Senol Citli
Zekeriya Oztemur
Mansur Kayatas

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Familial Mediterranean Fever (FMF) shows an autosomal recessive pattern of inheritance and affects certain ethnic groups. Disease is caused by mutations in MEFV gene and more than 180 mutations have been defined in affected individuals. Current study aimed to determine the frequency-type of the mutations for MEFV gene in Sivas-middle Anatolian city. The cohort was composed of 3340 patients. MEFV gene mutations were studied by multiplex PCR based reverse hybridization stripAssay method. Patients' clinical features were; family history: 68%, erysipelas-like erythema: 17.6%, fever: 89.9%, abdominal pain: 84.2%, peritonitis: 90.2%, arthritis: 33%, pleuritis: 14.2%, parental consanguinity: 21.2%. Current results revealed that M694V is the most frequent mutation (43.12%), followed by E148Q (20.18), M680I(G/C) (15.00%) and V726A (11.32%). The study population has a high rate of carriers and the E148Q mutation frequency was found to be highest when compared to the other regions of Turkey and other Mediterranean groups.

Indexed as

Carrier StateMutationAdolescentAdultAgedChildChild, PreschoolCytoskeletal ProteinsEthnicityFamilial Mediterranean FeverFemaleGene FrequencyGenotypeHumansMaleMiddle AgedCytoskeletal ProteinsMEFV protein, humanPyrin

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.